Company Name: Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated is a pharmaceutical company. The company is a developer of drugs that are designed to treat metabolic, oncologic and psychiatric disorders that are associated with the steroid hormone cortisol. Korlym®, the company’s first FDA approved product, is a treatment for endogenous Cushing’s syndrome.

Ticker Symbol: CORT (NASDAQ)

Company Website:

Social Media: Corcept Therapeutics LinkedIn

Headquarters: Menlo Park, CA